Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.49
Delayed Data
As of Apr 24
 +0.005 / +1.03%
Today’s Change
0.40
Today|||52-Week Range
0.73
-12.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization11.5K22.5K25.8K25.2K
 
 
 
 
 
 
Operating ExpensesGross Income-11.5K-22.5K-25.8K-25.2K
 
 
 
 
 
General Expenses6.5M7.2M7.9M7.3M
 
 
 
 
 
Research And Development4.3M4.8M5.4M4.9M
 
 
 
 
 
Total Operating Expenses6.6M7.2M7.9M7.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.6M-7.2M-7.9M-7.4M
 
 
 
 
 
Extraordinary Credit0.0010.9K--307.00
 
 
 
Extraordinary Charge-280.4K---1.9K--
 
 
 
Other Expenses452.9K33.0K253.0021.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.4M-7.2M-7.9M-7.3M
 
 
 
 
 
Net Income-6.4M-7.2M-7.9M-7.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS105.1M115.6M123.3M145.3M
 
 
 
 
 
Shares To Calculate EPS Diluted105.1M115.6M123.3M145.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.06-$0.06-$0.05
 
 
 
 
 
EPS Diluted-$0.06-$0.06-$0.06-$0.05
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account